Publications by authors named "Jinhuan Yin"
The FLAGELLIN-SENSITIVE2 (FLS2), a typical receptor kinase, recognizes the conserved 22 amino acid sequence in the N-terminal region of flagellin (flg22) to initiate plant defense pathways, which was intensively studied in the past decades. However, the dynamic regulation of FLS2 phosphorylation at the plasma membrane after flg22 recognition needs further elucidation. Through single-particle tracking, we demonstrated that upon flg22 treatment the phosphorylation of Ser-938 in FLS2 impacts its spatiotemporal dynamics and lifetime.
View Article and Find Full Text PDFA high resolution and wide range valve for micronewton cold gas thrusters.
Rev Sci Instrum
February 2024
Article Synopsis
- The paper discusses a new proportional valve designed for micronewton thrusters used in scientific satellites, emphasizing its role in controlling thrust to counter environmental disturbances.
- It features two independently controllable piezoelectric stacks: one compensates for valve core deformation, while the other acts as the main actuator to achieve high mass flow control resolution.
- Experimental tests showed impressive results, achieving a mass flow range of 0-675 μg/s with a resolution better than 0.1 μg/s, enhancing operational reliability even if one actuator fails.
Background: Lymph node dissection is essential for staging of pure solid lung adenocarcinoma and selection of treatment after surgical resection, particularly for stage I disease since the rate of lymph node metastasis can vary from 0 to 23.7%.
Methods: We retrospectively screened all adult patients (18 years of age or older) who underwent lobectomy for pure solid cT1N0M0 lung adenocarcinoma between January 2015 and December 2017 at our center.
Background: Although several clinical studies have laid the foundation for the adjuvant application of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), some questions remain unresolved. This real-world study aimed to address questions such as the effect of adjuvant chemotherapy prior to adjuvant EGFR-TKI therapy on survival outcomes, and the duration of adjuvant EGFR-TKI therapy,
Methods: Between October 2005 and October 2020, 227 consecutive patients with non-small cell lung cancer (NSCLC) who underwent complete pulmonary resections were included in this retrospective study. Patients received postoperative adjuvant chemotherapy followed by EGFR-TKI or adjuvant EGFR-TKI monotherapy.